Clarivate Plc
CLVT NYSE Services-Computer Processing & Data Preparation Financials FY2017βFY2025
What Clarivate Plc does
No business description yet.
- Legal name
- CLARIVATE PLC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001764046-26-000019
0001764046
Revenue and margins
Clarivate Plc had $2.5B of revenue in fiscal 2025, down 4.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $365M in fiscal 2025, 14.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Clarivate Plc returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count fell 2.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Clarivate Plc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $431M | $357M | $371M | $295M | $329M |
| Debt incl. finance leases | $5.5B | $5.0B | $4.8B | $4.5B | $4.5B |
| Net debt / EBITDA | 11.4x | β | β | 9.4x | 5.0x |
| Debt / equity | 0.5x | 0.7x | 0.8x | 0.9x | 0.9x |
| Interest coverage | β0.3x | β14.5x | β2.5x | β | β |
| Current ratio | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
| Quick ratio | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
| Total assets | $20.2B | $13.9B | $12.7B | $11.5B | $11.1B |
| Total liabilities | $8.3B | $7.1B | $6.7B | $6.4B | $6.2B |
| Shareholders' equity | $11.9B | $6.8B | $6.0B | $5.1B | $4.8B |
| Net debt (β = net cash) | $5.1B | $4.7B | $4.4B | $4.3B | $4.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 8 | 6 / 9 | 6 / 9 | 4 / 9 | 7 / 9 | 5 / 9 | 5 / 9 |
| Accruals ratio | β | β5.8% | β10.0% | β6.6% | β3.4% | β26.2% | β12.4% | β10.6% | β7.4% |
| Altman Z'' | β | β0.75 | β0.67 | 1.23 | 1.14 | β2.29 | β1.23 | β1.49 | β1.51 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $918M | $968M | $974M | $1.3B | $1.9B | $2.7B | $2.6B | $2.6B | $2.5B |
| Gross profit | β | β | $622M | $815M | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B |
| Operating income | β$147M | β$106M | β$82.5M | β$36.3M | β$87.0M | β$3.9B | β$735M | β$276M | $71.5M |
| Interest expense | $138M | $131M | $158M | $112M | $253M | $270M | $294M | β | β |
| Pretax income | β$285M | β$237M | β$248M | β$353M | β$258M | β$4.0B | β$1.0B | β$554M | β$194M |
| Income tax | β$21.3M | $5.6M | $10.2M | β$2.7M | $12.3M | β$28.9M | β$101M | $82.9M | $7.2M |
| Net income | β$264M | β$242M | β$259M | β$351M | β$271M | β$4.0B | β$911M | β$637M | β$201M |
| Net income to common | β$264M | β$242M | β$259M | β$351M | β$312M | β$4.0B | β$987M | β$668M | β$201M |
| Diluted EPS | β$1.22 | β$1.11 | β$0.94 | β$0.82 | β$0.61 | β$6.24 | β$1.47 | β$0.96 | β$0.30 |
| Diluted shares | 0.22B | 0.22B | 0.27B | 0.43B | 0.64B | 0.68B | 0.67B | 0.69B | 0.67B |
| Cash flow | |||||||||
| Cash from operations | $6.7M | β$26.1M | $118M | $264M | $324M | $509M | $744M | $647M | $629M |
| Capital expenditure | β | $45.4M | $69.8M | $108M | $119M | $203M | $243M | $289M | $263M |
| Free cash flow | β | β$71.5M | $47.7M | $156M | $205M | $306M | $502M | $358M | $365M |
| Depreciation and amortization | $228M | $237M | $201M | $303M | $538M | $711M | $708M | $727M | $757M |
| Stock-based compensation | $17.7M | $13.7M | $51.4M | $34.2M | $33.3M | $93.9M | $109M | $59.9M | $63.1M |
| Acquisitions | $7.4M | $23.5M | $68.4M | $2.9B | $3.9B | $24.8M | $5.4M | $32.0M | $0.0M |
| Dividends paid | β | β | β | $0.0M | $18.9M | $75.4M | $75.5M | $37.7M | $0.0M |
| Dividends and buybacks | β | β | β | $0.0M | $18.9M | $75.4M | $75.5M | $37.7M | $0.0M |
| Balance sheet | |||||||||
| Cash and short-term investments | $53.2M | $25.6M | $76.1M | $258M | $431M | $357M | $371M | $295M | $329M |
| Total debt | β | $2.1B | $1.6B | $3.5B | $5.5B | $5.0B | $4.7B | $4.5B | $4.4B |
| Finance lease liabilities | β | β | β | β | $30.8M | $31.3M | $30.3M | $29.3M | $28.1M |
| Current assets | β | $409M | $493M | $1.1B | $1.6B | $1.4B | $1.5B | $1.2B | $1.3B |
| Current liabilities | β | $644M | $651M | $1.4B | $1.9B | $1.6B | $1.6B | $1.4B | $1.6B |
| Property and equipment, net | β | $20.6M | $18.0M | $36.3M | β | β | β | β | β |
| Goodwill | $1.3B | $1.3B | $1.3B | $6.0B | $7.9B | $2.9B | $2.0B | $1.6B | $1.6B |
| Intangible assets | β | $2.0B | $1.8B | $7.4B | $10.4B | $9.4B | $9.0B | $8.4B | $8.0B |
| Total assets | β | $3.7B | $3.8B | $14.8B | $20.2B | $13.9B | $12.7B | $11.5B | $11.1B |
| Total liabilities | β | $2.7B | $2.5B | $5.8B | $8.3B | $7.1B | $6.7B | $6.4B | $6.2B |
| Preferred stock | β | β | β | $0.0M | $1.4B | $1.4B | $1.4B | $0.0M | β |
| Shareholders' equity | $1.3B | $1.1B | $1.2B | $9.0B | $11.9B | $6.8B | $6.0B | $5.1B | $4.8B |
| Margins | |||||||||
| Gross margin | β | β | 63.9% | 65.0% | 66.6% | 64.1% | 65.5% | 66.0% | 66.0% |
| Operating margin | β16.0% | β10.9% | β8.5% | β2.9% | β4.6% | β147.6% | β27.9% | β10.8% | 2.9% |
| EBITDA margin | 8.9% | 13.6% | 12.1% | 21.3% | 24.0% | β120.9% | β1.0% | 17.7% | 33.8% |
| Net margin | β28.8% | β25.0% | β26.5% | β28.0% | β14.4% | β148.9% | β34.7% | β24.9% | β8.2% |
| FCF margin | β | β7.4% | 4.9% | 12.4% | 10.9% | 11.5% | 19.1% | 14.0% | 14.9% |
| Returns | |||||||||
| Return on capital | β | β2.7% | β2.3% | β0.2% | β0.4% | β27.1% | β5.6% | β2.3% | 0.6% |
| Return on capital employed | β | β3.4% | β2.6% | β0.3% | β0.5% | β31.7% | β6.6% | β2.7% | 0.8% |
| Return on equity | β20.5% | β20.7% | β22.5% | β6.8% | β2.6% | β42.3% | β14.2% | β11.4% | β4.0% |
| Return on assets | β | β6.5% | β6.9% | β3.8% | β1.5% | β23.2% | β6.8% | β5.3% | β1.8% |
| Growth | |||||||||
| Revenue growth | β | 5.5% | 0.6% | 28.7% | 49.7% | 41.7% | β1.2% | β2.7% | β4.0% |
| FCF growth | β | β | β | 226.3% | 31.8% | 49.2% | 63.7% | β28.7% | 2.2% |
| Share count change | β | 0.3% | 25.9% | 55.9% | 50.1% | 5.9% | β1.0% | 3.3% | β2.9% |
| Financial health | |||||||||
| Net debt / EBITDA | β | 15.4x | 13.3x | 12.2x | 11.4x | β | β | 9.4x | 5.0x |
| Debt / equity | β | 2.0x | 1.3x | 0.4x | 0.5x | 0.7x | 0.8x | 0.9x | 0.9x |
| Interest coverage | β1.1x | β0.8x | β0.5x | β0.3x | β0.3x | β14.5x | β2.5x | β | β |
| Current ratio | β | 0.6x | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
| Quick ratio | β | 0.6x | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
| Capital allocation | |||||||||
| Capex / revenue | β | 4.7% | 7.2% | 8.6% | 6.3% | 7.6% | 9.2% | 11.3% | 10.7% |
| Stock comp / revenue | 1.9% | 1.4% | 5.3% | 2.7% | 1.8% | 3.5% | 4.1% | 2.3% | 2.6% |
| Payouts / FCF | β | β | β | 0.0% | 9.2% | 24.6% | 15.0% | 10.5% | 0.0% |
| Quality scores | |||||||||
| Piotroski F-score | β | β | 4.0 | 6.0 | 6.0 | 4.0 | 7.0 | 5.0 | 5.0 |
| Altman Z'' | β | β0.7 | β0.7 | 1.2 | 1.1 | β2.3 | β1.2 | β1.5 | β1.5 |
| Accruals ratio | β | β5.8% | β10.0% | β6.6% | β3.4% | β26.2% | β12.4% | β10.6% | β7.4% |
Source: SEC EDGAR XBRL filings (CIK 0001764046). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.